Great honour to have Michael Chiusolo, speaking at our recent conference

It was a great honour to have Michael Chiusolo, Executive Director & Commercial Women's Health Portfolio Lead at Organon speaking at our recent conference in Montreux on ¨Empowering women’s health: Creating a winning business strategy¨.

Organon spun out of Merck & Co in June 2021 with the women’s health, established brands and biosimilars portfolios. The women’s health business started with no development pipeline and therefore business development was essential to build the franchise. Michael shared valuable insights based on nearly 10 subsequent transactions. The guidance was to invest effort in crafting a very well thought through and detailed strategy, ensuring full alignment of stakeholders across functions. It's important to pursue a deliberate, disciplined strategy, but if an opportunistic deal perfectly fits your footprint then to look at it seriously – ¨80% strategy, 20% opportunism¨. It helps to be crystal clear on what you can’t do to save wasted effort, e.g. due diligence on software offerings. While being laser focused on strategy, it’s important to be flexible on execution, and open to a variety of deal structures. Opportunism can be used to evolve strategy over time.